Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases

American Journal of Clinical Pathology

Volumn 117, Issue 2, 2002, Pages 316-324

  Tozzoli, Renato ^a   Bizzaro, Nicola ^a   Tonutti, Elio ^a   Villalta, Danilo ^a   Bassetti, Danila ^a   Manoni, Fabio ^a   Piazza, Anna ^a   Pradella, Marco ^a   Rizzotti, Paolo ^a  

^a Ospedale Civile   (Italy)

Author keywords

Antinuclear antibodies; Autoimmune rheumatic disease; Dermatopolymyositis; Guidelines; Sj gren syndrome; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA;

ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; CLINICAL PROTOCOL; HEALTH EDUCATION; HUMAN; IMMUNOASSAY; LABORATORY TEST; PATHOLOGIST; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE;

ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNE DISEASES; HUMANS; IMMUNOLOGIC TESTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MONITORING, IMMUNOLOGIC; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES;

EID: 0036320108     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/Y5VF-C3DM-L8XV-U053     Document Type: Review

References (69)

1. Credibility, cookbook medicine and common sense: Guidelines and the college
2. Evidence-based medicine: What it is and what it isn't
3. Evidence-based clinical biochemistry
4. Presentation of two bone marrow elements: The "tart" and "L.E." cell
5. Standards of care: The value and importance of standardization
6. Auto-immunité, auto-anticorps et maladie auto-immunes
7. The 1982 revised criteria for the classification of systemic lupus erythematosus
8. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
9. Preliminary criteria for the classification of Sjögren's syndrome: Results of a prospective concerted action supported by the European Community
10. Classification criteria for polymyositis and dermatomyositis
11. Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis
12. Comparative study of 4 diagnosis criteria sets for mixed connective tissue diseases in patients with anti-RNP antibodies
13. The consensus workshop for the detection of autoantibodies to intracellular antigens in rheumatic diseases
14. The consensus workshop for the detection of autoantibodies to intracellular antigens in rheumatic diseases: 1989-1992
15. International cooperative activities in standardization of antinuclear antibodies
16. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens
17. Setting the scene
18. Epidemiology and estimated population burden of selected autoimmune diseases in the United States
19. Antinuclear, anticytoplasmic and anti-Sjögren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors
20. Range of antinuclear antibodies in "healthy" individuals
21. Autoantibodies in the diagnosis of systemic rheumatic diseases
22. Antinuclear antibody testing; a study of clinical utility
23. Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): Use of reference sera of defined antibody specificity
24. Antinuclear antibodies
25. Detection of antinuclear antibodies by immunofluorescence
26. Use of HEp-2 cells in the IF test for detection of antinuclear antibodies
27. Detection of autoantibodies to SSA/Ro by indirect immunofluorescence using a transfected and overexpressed human 60 kd Ro autoantigen in HEp-2 cells
28. The SS-A/Ro antigen
29. Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation
30. Standards and reference preparations
31. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: A collaborative study with the biomedical industry
32. Use of a standard curve improves precision and concordance of antinuclear antibody measurements
33. Reference reagents for antinuclear antibodies
34. Standardisation of the quantitative determination of antinuclear antibodies (ANAs) with a homogeneous pattern
35. Diagnosis of autoimmune disease
36. Autoantibodies to centromere protein F
37. What are natural autoantibodies?
38. Current concepts and advances in clinical laboratory testing for autoimmune diseases
39. Cascade testing for autoantibodies in connective tissue diseases
40. Clinical significance of autoantibodies to PCNA
41. Serological findings in patients with "ANA" negative lupus
42. Screening for antinuclear antibodies by enzyme immunoassay
43. Clinical significance of antinuclear antibodies: Comparison of detection with immunofluorescence and enzyme-linked immunosorbent assay
44. An enzyme immunoassay screening test for the detection of total antinuclear antibodies
45. Detection of antinuclear antibodies from patients with systemic rheumatic diseases by ELISA using HEp-2 cell nuclei
46. Comparison of antinuclear antibody testing methods: Immunofluorescence assay versus enzyme immunoassay
47. Comparison of EIA methods against IFA method for ANA qualitative screening
48. Systemic lupus erythematosus: Antibodies to DNA, DNA binding proteins, and histones
49. Anti-native DNA detection by the Crithidia luciliae method: An improved guide to the diagnosis and clinical management of systemic lupus erythematosus
50. Deoxyribonucleic acid antibody: A method to detect primary interaction with deoxyribonucleic acid
51. An immunofluorescent method using Crithidia luciliae to detect antibodies to double stranded DNA
52. Measurement of antibodies to DNA
53. dsDNA autoantibodies
54. Prognostic value of anti-dsDNA in SLE
55. Prevention of relapses in systemic lupus erythematosus
56. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus
57. Anti-double stranded DNA antibodies in systemic lupus erythematosus: Detection and clinical relevance of IgM-class antibodies
58. Importance of detection of SS-A/Ro autoantibody screening immunofluorescence tests for autoantibodies to nuclear antigens
59. Receiver-operating characteristics (ROC) plots: A fundamental valuation tool in clinical medicine
60. SS-A (Ro) autoantibodies
61. Detection of anti-Ro(SSA) antibodies in autoimmune diseases: Comparison of five methods
62. Autoantigens in connective tissue disease
63. Immunoblotting and dot blotting
64. Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro/SS-A protein
65. Variabilità analitica nella determinazione degli autoanticorpi anti-ENA: Risultati preliminari di un'esperienza di VEQ
66. Sensitivity and specificity of immunological methods for the detection of anti-topoisomerase I (Scl70) autoantibodies: Results of a multicenter study
67. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificity, I: Precision, sensitivity, and specificity
68. Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases: Analytical variability and diagnostic sensitivity of 4 methods